AU2002335965A1 - Pedf biopolymer markers predictive of alzheimers disease - Google Patents

Pedf biopolymer markers predictive of alzheimers disease

Info

Publication number
AU2002335965A1
AU2002335965A1 AU2002335965A AU2002335965A AU2002335965A1 AU 2002335965 A1 AU2002335965 A1 AU 2002335965A1 AU 2002335965 A AU2002335965 A AU 2002335965A AU 2002335965 A AU2002335965 A AU 2002335965A AU 2002335965 A1 AU2002335965 A1 AU 2002335965A1
Authority
AU
Australia
Prior art keywords
pedf
alzheimers disease
biopolymer markers
markers predictive
predictive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002335965A
Inventor
George Jackowski
John Marshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syn X Pharma Inc
Original Assignee
Syn X Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syn X Pharma Inc filed Critical Syn X Pharma Inc
Publication of AU2002335965A1 publication Critical patent/AU2002335965A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2002335965A 2001-11-23 2002-10-31 Pedf biopolymer markers predictive of alzheimers disease Abandoned AU2002335965A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99336801A 2001-11-23 2001-11-23
US09/993,368 2001-11-23
PCT/CA2002/001641 WO2003046566A2 (en) 2001-11-23 2002-10-31 Pedf biopolymer markers predictive of alzheimers disease

Publications (1)

Publication Number Publication Date
AU2002335965A1 true AU2002335965A1 (en) 2003-06-10

Family

ID=25539457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002335965A Abandoned AU2002335965A1 (en) 2001-11-23 2002-10-31 Pedf biopolymer markers predictive of alzheimers disease

Country Status (3)

Country Link
JP (1) JP2005510722A (en)
AU (1) AU2002335965A1 (en)
WO (1) WO2003046566A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201322094D0 (en) * 2013-12-13 2014-01-29 Electrophoretics Ltd Methods and compositions relating to alzheimers disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797402B1 (en) * 1999-07-15 2004-03-12 Biomerieux Stelhys USE OF A POLYPEPTIDE FOR DETECTING, PREVENTING OR TREATING A CONDITION ASSOCIATED WITH A DEGENERATIVE, NEUROLOGICAL OR AUTOIMMUNE DISEASE
WO2001075454A2 (en) * 2000-04-03 2001-10-11 Oxford Glycosciences (Uk) Ltd. Diagnosis and treatment of alzheimer's disease

Also Published As

Publication number Publication date
WO2003046566A2 (en) 2003-06-05
WO2003046566A3 (en) 2003-09-04
JP2005510722A (en) 2005-04-21

Similar Documents

Publication Publication Date Title
AU2002332079A1 (en) Clustering
AU2002232193A1 (en) Microchip
AU2002336843A1 (en) Biopolymer markers predictive of alzheimers disease
AU2002367266A1 (en) Disease markers for renal diseaes and utilization thereof
AU2003290939A1 (en) Replication of biological tiussue
AU2002335964A1 (en) Ig lambda biopolymer markers predictive of alzheimers disease
AU2001288973A1 (en) Non-genetic based protein disease markers
AU2002335969A1 (en) Complement c3 precursor biopolymer markers predictive of alzheimers disease
AU2002335965A1 (en) Pedf biopolymer markers predictive of alzheimers disease
AU2002335975A1 (en) Apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002249453A1 (en) Enzyme and snp marker for disease
AU2002336842A1 (en) Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002335963A1 (en) Protein biopolymer markers predictive of alzheimers disease
AU2002306488A1 (en) Photochemical amplified immunoassay
AU2001277236A1 (en) Shoe construction
AU2002335967A1 (en) Protein biopolymer markers predictive of alzheimers disease
AU2002335971A1 (en) Fibronectin precursor biopolymer marker predictive of alzheimers disease
AU2002335972A1 (en) Glycoprotein and apolipoprotein biopolymer markers predictive of alzheimers disease
AU2002335966A1 (en) Plasma protease c1 biopolymer markers predictive of alzheimers disease
AU2002367501A1 (en) Improved shoe
AU2002336018A1 (en) Protein biopolymer markers predictive of type ii diabetes
AU2002335968A1 (en) Protein biopolymer markers indicative of a disease state
AU2002232179A1 (en) Novel disease marker
AU2001287897A1 (en) Manipulation of spermatozoa
AU2002336019A1 (en) Apolipoprotein biopolymer markers predictive of type ii diabetes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase